Search results
Ultratech re-enters race to buy Orient Cement - ET RealEstate
The Economic Times· 4 days agoKumar Mangalam Birla flagship UltraTech is in advanced negotiations with the promoter of Orient...
Does age matter for hair re-growth post hair transplant? | - Times of India
The Times of India· 2 hours agoHair transplantation is a transformative procedure sought by many individuals experiencing hair...
Shabana Azmi on Honey Irani’s reaction to her affair with Javed Akhtar: ‘She felt rejected’
Indian Express· 5 hours agoAzmi revealed that Akhtar put in a lot of effort to rebuild a healthy dynamic with Irani. Of course,...
NEET paper leak case: Impersonation in focus as CBI takes over 7 cases
Indian Express· 4 days agoDays after taking over the investigation in three states in connection with the National Eligibility...
Addressing the disconnect between MBA education and real-world demands to minimise high attrition...
Hindustan Times· 3 hours agoAccording to a recent report by Deloitte titled Campus Workforce Trends 2024, the pan-India...
Pleasant experience getting my work done at the KA-03 Bangalore RTO | Team-BHP
Team-BHP· 3 days agoInitially, I thought of involving some RTO agent but decided to give it a try myself and I was...
'3 kinds of investors': REC, PFC get upside target prices; Bernstein says this on 2 multibagger PSU...
Business Today· 4 days agoBernstein said the two PSU power sector lenders were forgotten for a decade but now have a market...
Margin, deposit pressure likely to spoil banks’ June quarter show
Livemint· 13 hours agoFor instance, state-owned Punjab National Bank reported quarter-on-quarter deposits growth of 2.8%,...
Premium valuation of defence companies should sustain 3-5 years down the line: Binod Modi
The Economic Times· 12 hours agoBinod Modi, Portfolio Manager, Sharekhan, BNP Paribas, says while defence stocks should do well, in...
Tracon mulls strategic options after sarcoma drug fails Phase II trial
Pharmaceutical Technology· 6 days ago-based Jiangsu Alphamab Biopharmaceuticals and 3D Medicines in 2019. In 2021, envafolimab was...